Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
PRINCETON, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the âCompanyâ or âY-mAbsâ) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development an...